December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells
Oct 9, 2024, 16:24

Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells

Jonathan Licht, Director of the UF Health Cancer Center, shared a post on X:

Our paper on how tumor suppressor KDM6A controls MHC-I and II expression in multiple myeloma cells is out in print in Blood Journal.

KDM6A loss can be ameliorated by treatment of cells with an HDAC3 inhibitor, restoring MHC expression.”

KDM6A controls immunogenicity in MM

Authors: Jerome Moreaux.

Jonathan Licht: How KDM6A controls MHC-I and II expression in multiple myeloma cells